Investor's Business Daily on MSN

Merck Takes On Amgen, Regeneron, Lowering Stubbornly High Cholesterol By 60%

Merck said Saturday its new pill — a potential rival to Regeneron and Amgen — lowered stubbornly high cholesterol by almost ...